Perimenopause and Joint Pain: Why It Starts Earlier Than You Think
Stiff hips getting out of the car. Knees that complain on the stairs. Hands that need a few minutes before they work properly in the morning. If you are in your forties, this is not too early, and it now has a name in the medical literature.
You are not too young. Most women start the menopausal transition between 45 and 55, and it runs for years before the final period, so joint aches in your early forties are on schedule rather than premature.
The maths nobody does out loud
Here is the arithmetic that clears up most of the confusion. The average age of menopause in the United States is 52. The National Institute on Aging says most women begin the menopausal transition between 45 and 55, and that menopause-related symptoms can run anywhere from two to eight years.
Work backwards from that. If your periods stop at 52 and symptoms started six years earlier, they started at 46. Joint and muscle discomfort sits on the NIA's own list of menopausal transition symptoms. So aching knees at 46 are not early, not unusual, and not a sign you have aged prematurely. They are roughly on time.
The reason it feels early is that nobody mentions this part. Hot flashes get discussed. Irregular periods get discussed. Joints get filed under general wear and tear, and women spend a year wondering whether they have arthritis at 44.
02
It has a name now
In 2024, a review in Climacteric by Wright, Schwartzman, Itinoche and Wittstein proposed a term for this: the musculoskeletal syndrome of menopause. The point of naming it was to stop these symptoms being treated as separate, unrelated midlife complaints.
The numbers in that paper are worth sitting with. More than 70 percent of women going through menopause experience musculoskeletal symptoms. Roughly 25 percent are significantly disabled by them. Over 47 million women enter menopause each year.
Under that single umbrella the authors group joint pain, loss of muscle mass, loss of bone density and the progression of osteoarthritis. That last one matters: falling estrogen may be accelerating osteoarthritis rather than being an alternative explanation for it. Their argument is that clinicians and patients both routinely underestimate how much estrogen loss contributes, and that the cost of missing it is delayed treatment.
More than 70% of women going through menopause experience musculoskeletal symptoms, and around 25% are significantly disabled by them. Wright et al., Climacteric, 2024
03
Fluctuation, not decline
Perimenopause and post-menopause are not the same hormonal situation, and the difference explains why your symptoms may be maddeningly inconsistent.
During perimenopause, estrogen and progesterone do not glide downwards. They swing, sometimes spiking above premenopausal levels before dropping sharply. After the final period, estrogen settles low and stays there. Fluctuation produces variability; a settled low level produces something steadier.
| Perimenopause | After menopause | |
|---|---|---|
| Hormone pattern | Uneven fluctuation, sometimes above premenopausal peaks | Sustained low estrogen |
| Symptom pattern | Comes and goes, often loosely tracking an irregular cycle | More constant |
| Typical timing | Years before the final period, commonly from the mid-forties | From 12 months after the final period |
| What it means for you | Inconsistency is expected and not evidence of another problem | Easier to judge whether something is helping |
- A good fortnight followed by a bad one is characteristic of perimenopause, not a sign you imagined it
- It also makes it genuinely hard to judge whether any intervention is working, so give anything you try several months
- Sleep is the confounder worth watching: disrupted sleep is both a perimenopausal symptom and independently linked to greater pain sensitivity
04
What it actually feels like, and what it does not
Pattern recognition is more useful here than any single symptom, because the thing you most want to avoid is attributing an unrelated condition to hormones for two years.
- Stiffness and dull aching rather than sharp, pinpointed pain
- Several joints at once, commonly hips, knees, hands and lower back
- Worse in the morning, or after sitting through a long drive or a day at a desk
- Eases as you move through the day rather than worsening with use
- Varies week to week, sometimes loosely following an irregular cycle
- One joint only, particularly if it is hot, swollen or red
- Pain that worsens with movement rather than easing
- Severe or steadily worsening pain, or pain that wakes you
- Thyroid disorders and inflammatory arthritis both cause joint pain, both become more common at this age, and both get missed when everything is blamed on hormones. Asking for the relevant bloods is reasonable.
05
The part most articles get wrong
This is where you would normally be told which supplement fixes this. We are not going to do that, because the research does not support it and pretending otherwise would be the easiest way to lose your trust.
A 2018 review in Post Reproductive Health by Fiona Watt looked at musculoskeletal pain and menopause and reached a conclusion worth quoting directly: while the association between estrogen deficiency and musculoskeletal pain appears strong, a causal link is lacking, and research in this specific symptomatic population remains limited.
That has a consequence people skip past. Curcumin and boswellia have a reasonable general anti-inflammatory evidence base. That evidence does not come from trials in perimenopausal women. Nobody has run the study that would let anyone honestly claim a particular ingredient treats hormone-related joint pain. When a brand tells you it has, they are extrapolating and not saying so.
It is a real gap rather than a rhetorical one. A systematic review and meta-analysis of 93,021 women published in JBJS Open Access in 2026 shows the epidemiology is finally getting serious attention. The intervention trials in this population have not caught up.
06
What is actually worth doing
Stripping out everything unproven leaves less than the internet promises, but what remains is not trivial.
The 2024 review lists muscle mass loss and bone density loss alongside joint pain. Loading muscle and bone is the one intervention that addresses all three, and it is the thing most commonly skipped in favour of a capsule. Twice a week is enough to matter.
Perimenopausal stiffness characteristically eases with motion. That makes gentle movement first thing in the morning more useful than waiting for it to settle, which is the opposite of what the instinct says.
Treating disrupted sleep as a pain intervention rather than a separate complaint is one of the more useful reframes available here, given how consistently poor sleep raises pain sensitivity.
The whole point of naming the syndrome was to prompt earlier consideration of treatment. Risks and benefits are individual and depend on your age, history and other symptoms, so this belongs with a clinician who knows your full picture rather than an article.
On supplements, our own position is the one we would want from someone selling them. Joint Axis Pro contains glucosamine sulfate, MSM, hyaluronic acid, boswellia, curcumin and piperine at doses printed on the label, and none of those ingredients has been trialled specifically in perimenopausal women. If you want to judge any joint supplement, ours included, on its merits rather than its marketing, our guide to reading a joint supplement label line by line is more useful than anything we could tell you about our own bottle.
07
What to expect
- Symptoms may settle once hormones stabilise, or shift into a steadier post-menopausal pattern — individual courses vary widely
- Judge anything you try over months, not weeks, because week-to-week variation will otherwise fool you both ways
- Bone and muscle are changing alongside your joints, which is an argument for strength work now rather than later
- Getting thyroid and inflammatory arthritis ruled out early is worth the appointment
- Nobody can tell you which ingredient will help, because that study has not been done
08
The underlying research
09
Frequently asked questions
References
- Wright VJ, Schwartzman JD, Itinoche R, Wittstein J. The musculoskeletal syndrome of menopause. Climacteric. 2024;27(5):466–472. PubMed
- Watt FE. Musculoskeletal pain and menopause. Post Reproductive Health. 2018. Post Reproductive Health
- Musculoskeletal Manifestations of Perimenopause: A Systematic Review and Meta-Analysis of 93,021 Women. JBJS Open Access. 2026. DOI
- National Institute on Aging. What Is Menopause? nia.nih.gov
- Szoeke CEI, Cicuttini FM, Guthrie JR, Dennerstein L. The relationship of reports of aches and joint pains to the menopausal transition: a longitudinal study. Climacteric. 2008;11(1):55–62. PubMed
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is educational and is not medical advice. Speak with a qualified healthcare provider about joint pain, and particularly before starting a new supplement or considering changes to a hormone therapy regimen.
Six ingredients, every dose printed
Glucosamine sulfate 1,500 mg, MSM 500 mg, hyaluronic acid 180 mg, boswellia serrata 200 mg at 30% AKBA, curcumin 160 mg at 95%, piperine 8 mg. No proprietary blend. Launching November 2026.
See the full formula